CONMED CORPORATION Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
CONMED CORPORATION (CNMD) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of -1.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-17
- CONMED CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2025 was -1.00%.
- CONMED CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was -0.20%.
- CONMED CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2023 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month |
|---|---|
| 2025-12-31 | -1.00% 10-K · filed 2026-02-17 |
| 2024-12-31 | -0.20% 10-K · filed 2026-02-17 |
| 2023-12-31 | 0.00% 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |